ArticleFrontiers in pediatrics2026
Construction and validation of a predictive model for recurrent wheezing risk within one year after initial hospitalization for RSV lower respiratory tract infection in preschool children.
Article in Frontiers in pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Respiratory syncytial virus (RSV) is a leading cause of lower respiratory tract infection (LRTI) in preschool children and is strongly associated with subsequent recurrent wheezing; however, predictive tools for identifying high-risk children are lacking. This study aimed to construct and validate a model for predicting recurrent wheezing within one year after initial hospitalization for RSV LRTI. Methods: This retrospective study included preschool children with wheezing hospitalized for their first RSV LRTI at our hospital between April 2020 and March 2025. Patients were divided into recurrence and non-recurrence groups based on recurrent wheezing within one year post-discharge. Demographic and clinical data, and serum biomarkers (25-hydroxyvitamin D3 [25-(OH) D3], interleukin-6 [IL-6], interferon- Results: A total of 480 patients were included, with 276 experiencing recurrence and 204 without. Multivariate analysis identified independent predictors: younger age (OR = 0.398, Conclusion: This nomogram, incorporating age, passive smoking, hospital stay, 25-(OH) D3, IL-6, IFN-
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.